Cultural Foundation
Author:
Skye Bioscience, Inc.
UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
May 13, 2026
Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
May 12, 2026
Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit
April 7, 2026
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development
April 2, 2026
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 11, 2026